International Flavors & Fragrances Q3 Earnings Call Highlights

International Flavors & Fragrances (IFF) reported Q3 sales of $566M in Health & Biosciences, up 1%. Full-year sales are expected to be $7.5B-$7.6B, with adjusted EBITDA of $1.55B-$1.6B. IFF faces cost pressures, particularly in Health & Biosciences, due to higher input costs. The company plans to divest its Food Ingredients business for $4.3B by mid-2027 and has completed other divestitures. Free cash flow for the first nine months of 2026 was $371M, up $245M year-over-year.

Original reporting
Published Nov 8, 2026, 4:14 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 8, 2026, 4:31 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
International Flavors & Fragrances Q3 Earnings Call Highlights — source image
Decision brief

The 30-second read

$IFFBearishMed
01

Why it matters

The guidance downgrade and margin compression suggest short‑term downside risk, but the $500M share buyback and cash flow improvements could mitigate the impact.

02

Market read

The earnings release provides fresh material for traders evaluating consumer‑goods exposure and cost‑inflation dynamics.

03

What to watch

Accelerated share repurchase and strong free cash flow may provide upside if investors focus on balance‑sheet strength.

Relevance 8/10Novelty 8/10Timing: post‑earnings today

Background

International Flavors & Fragrances (NYSE: IFF) reported Q3 performance and updated its FY outlook, while outlining ongoing divestitures and cost‑reduction plans.

Company-level read

Ticker impact

$IFFBearishHigh confidence
Context

IFF disclosed Q3 results with full-year sales guidance of $7.5‑$7.6B and a sequential margin decline, plus a $4.3B divestiture slated for 2027.

Expected impact

likely pressure as investors price in higher costs and lower margins

Evidence & confidence

The earnings call highlighted cost inflation, margin compression and a modest sales outlook, which typically weigh on the stock.

Market effects

Food ingredients and fragrance sector may see broader cost‑inflation concerns.

European and North American fragrance markets could feel pressure from higher input costs.

Large‑cap consumer‑goods supplier guidance influences broader consumer discretionary sentiment.

Counterpoint

If the divestiture proceeds smoothly, cash generation could support a rebound later in the year.

Key entities

  • International Flavors & Fragrances

    NYSE‑listed producer of flavors and fragrances.

Related articles

$IFFMed

International Flavors & Fragrances Inc (IFF) (Q3 2026) Earnings Call

International Flavors & Fragrances Inc (IFF) reported challenges in its Health business due to reduced consumer spending in the US and Europe. The company expects higher costs in Q4 2026, with net price to input costs remaining unfavorable. Profitability margins are expected to moderate due to seasonality and higher costs. IFF faces execution risks related to the separation of its Food Ingredients business.

$IFFHigh

BofA downgrades International Flavors & Fragrances stock rating on valuation concerns

BofA downgraded International Flavors & Fragrances (IFF) to Underperform, lowering its price target to $91. IFF reported Q3 adjusted EBITDA of $403M, beating estimates. Despite strong results, BofA cited valuation concerns, softness in non-Taste businesses, and rising costs. IFF's stock declined post-earnings due to near-term margin concerns, though management raised full-year guidance.

$IFFHighAI 8/10

Intl Flavors (IFF) Q3 2026 Earnings Call Transcript

Intl Flavors (IFF) reported Q3 2026 earnings with 5% revenue growth and 6% EBITDA increase, driven by strong performances in taste and scent segments. The company raised its full-year guidance, completed a $500M share repurchase, and announced strategic divestitures, including the sale of its food ingredients business for $4.3B. Free cash flow rose to $371M, up $245M YoY. IFF expects near-term softness in Health & Biosciences but remains confident in its growth strategy.

$IFFMedAI 9/10

IFF Q3 2026 slides: solid growth tempered by margin headwinds

International Flavors & Fragrances (IFF) reported Q3 2026 earnings with revenue of $1.94B and adjusted EPS of $0.83, beating expectations. Shares fell 3.83% due to margin concerns and guidance for softer Q4 profitability. IFF highlighted growth in Taste, Scent, and Health & Biosciences segments, along with a $4.3B sale of its Food Ingredients business and a $2.5B capital return program. Free cash flow improved to $371M, up $245M YoY.

$IFFHighAI 8/10

Key facts: IFF Beats Q3; Raises Outlook, Completes Buyback

IFF reported Q3 2026 sales of $1.942B, up 4% YoY, and adjusted EBITDA of $403M, up 5%. The company raised its 2026 sales and EBITDA outlooks but warned of lower Q4 profitability. IFF completed a $500M share buyback and plans to separate its Food Ingredients business by Q2 2027. Analysts' average 12-month price target is $98.25, implying 7% upside.